Top

International Journal of Mental Health and Addiction

Published in:

01-06-2017

User Experiences of Development of Dependence on the Synthetic Cannabinoids, 5f-AKB48 and 5F-PB-22, and Subsequent Withdrawal Syndromes

Authors: Marie Claire Van Hout, Evelyn Hearne

Published in: International Journal of Mental Health and Addiction | Issue 3/2017

Abstract

Emergence of synthetic cannabinoids (SCBs) in herbal smoking mixtures is a public health concern. New SCB’s such as 5f-AKB48 and 5F-PB-22 have been detected in French seizures and in sudden death post mortems in the US. The aim was to describe development of dependence on herbal smoking mixtures containing the SCB’s, 5f-AKB48 and 5F-PB-22 and subsequent withdrawal syndromes. Dependent users of herbal smoking mixtures known to contain the SCB’s 5f-AKB48 and 5F-PB-22 with an average Severity of Dependence Score (SDS) of 13 were interviewed using a structured guide (three males/three females). Narratives were analysed using the Empirical Phenomenological Psychological (EPP) five step method. Six themes with 68 categories emerged from the analysis. Themes are illustrated as 1) Networks and Product Availability; 2) Drivers and Motives for Use; 3) Effect and Pathways toward Dependence; 4) Poly Substance Use and Comparisons to Natural Cannabis; 5) Dependence and Withdrawal and 6) Self-detoxification Attempts. Two higher levels of abstraction above these theme-levels emerged from the data, with sole use of herbal smoking mixtures containing 5f-AKB48 and 5F-PB-22 centering on the interplay between intense cravings, compulsive all-consuming seeking, use and re-dose behaviours, and fear of the psychiatric and self-harms caused when in withdrawal. This is the first study describing dependence and withdrawal experiences in users dependent on 5f-AKB48 and 5F-PB-22. Given the potential for adverse psychiatric and physical consequences of dependent use, further development of specific clinical responses and clinical research around toxicity and withdrawal severity are warranted.

Arfken, C. L., Owens, D., Madeja, C., & DeAngelis, C. (2014). Exploratory comparative study on the diffusion of synthetic cannabinoids and synthetic cathiones. Journal of Psychoactive Drugs, 46, 362–368. doi:10.1080/02791072.2014.959214.CrossRefPubMed

Auwärter, V., Dresen, S., Weinmann, W., Müller, M., Pütz, M., & Ferreirós, N. (2009). ‘spice’ and other herbal blends: harmless incense or cannabinoid designer drugs? Journal of Mass Spectrometry, 44, 832–837. doi:10.1002/jms. 1558.CrossRefPubMed

Banerji S, Deutsch CM, Bronstein AC (2010) SPICE Ain’t So Nice. http://rmpdc.org/Portals/23/Spice Poster Final 2010.pdf Accessed May 22nd 2015.

Barratt, M. J., Cakic, V., & Lenton, S. (2013). Patterns of synthetic cannabinoid use in Australia. Drug and Alcohol Review, 32, 141–146. doi:10.1111/j.1465-3362.2012.00519.x.CrossRefPubMed

Baumann, M. H., Solis Jr., E., Watterson, L. R., Marusich, J. A., Fantegrossi, W. E., & Wiley, J. L. (2014). Baths salts, spice, and related designer drugs: the science behind the headlines. The Journal of Neuroscience, 34, 15150–15158. doi:10.1523/JNEUROSCI.3223-14.2014.CrossRefPubMedPubMedCentral

Bebarta, V. S., Ramirez, S., & Varney, S. V. (2012). Spice: A new “legal” herbal mixture abused by young active duty military personnel. Substance Abuse, 33, 191–194. doi:10.1080/08897077.2011.637610.CrossRefPubMed

Behonick, G., Shanks, K. G., Firchau, D. J., Mathur, G., Lynch, C. F., Nashelsky, M., Jaskierny, D. J., & Meroueh, C. (2014). Four postmortem case reports with quantitative detection of the synthetic cannabinoid, 5FPB22. Journal of Analytical Toxicology, 38, 559–562. doi:10.1093/jat/bku048.CrossRefPubMedPubMedCentral

Berry-Caban, C. S., Ee, J., Ingram, V., Berry, C. E., & Kim, E. H. (2013). Synthetic cannabinoid overdose in a 20-year-old Male US soldier. Substance Abuse, 34, 70–72. doi:10.1080/08897077.2012.677754.CrossRefPubMed

Brents, L. K., & Prather, P. L. (2014). The K2/spice phenomenon: emergence, identification, legislation and metabolic characterization of synthetic cannabinoids in herbal incense products. Drug Metabolism Reviews, 46, 72–85. doi:10.3109/03602532.2013.839700.CrossRefPubMed

Brents, L. K., Reichard, E. E., Zimmerman, S. M., Moran, J. H., Fantegrossi, W. E., & Prather, P. L. (2011). Phase I hydroxylated metabolites of the K2 synthetic cannabinoid JWH-018 retain in vitro and in vivo cannabinoid 1 receptor affinity and activity. PloS One, 6, e21917. doi:10.1371/journal.pone.0021917.CrossRefPubMedPubMedCentral

Brents, L. K., Gallus-Zawada, A., Radominska-Pandya, A., Vasilievik, T., Prisinzano, T. E., Fantegrossi, W. E., Moran, J. H., & Prather, P. L. (2012). Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to partial agonist activity. Biochemical Pharmacology, 83, 952–961. doi:10.1016/j.bcp.2012.01.004.CrossRefPubMedPubMedCentral

Bright, S. J., Bishop, B., Kane, R., Marsh, A., & Barratt, M. J. (2013). Kronic hysteria: exploring the intersection between Australian synthetic cannabis legislation, the media, and drug-related harm. The International Journal on Drug Policy, 24, 231–237. doi:10.1016/j.drugpo.2012.12.002.CrossRefPubMed

Bryner J (2010) Fake weed, real drug: K2 causing hallucinations in teens. In: Live Science. Available via DIALOG. http://www.livescience.com/health/fake-marijuana-k2-hallucinations-100303.html . Accessed March 16th 2010.

Budney, A. J., & Stanger, C. (2012). Cannabis use and misuse. In J. M. Rey (Ed.), IACAPAP e-textbook of child and adolescent mental health (p. G2). Geneva: International Association for Child and Adolescent Psychiatry and Allied Profession.

Castellanos, D., Singh, S., Thornton, G., Avila, M., & Moreno, A. (2011). Synthetic cannabinoid use: A case series of adolescents. The Journal of Adolescent Health, 49, 347–349. doi:10.1016/j.jadohealth.2011.08.002.CrossRefPubMed

Caviness, C. M., Tzilos, G., Anderson, B. J., & Stein, M. D. (2015). Synthetic cannabinoids: use and predictors in a community sample of young adults. Substance Abuse, 36, 368–373. doi:10.1080/08897077.2014.9591.CrossRefPubMed

Chung, T., Martin, C. S., Cornelius, J. R., & Clark, D. B. (2008). Cannabis withdrawal predicts severity of cannabis involvement at 1-year follow-up among treated adolescents. Addiction, 103, 787–799. doi:10.1111/j.1360-0443.2008.02158.x.CrossRefPubMedPubMedCentral

Coffey, C., Carlin, J. B., Degenhardt, L., Lynskey, M., Sanci, L., & Patton, G. C. (2002). Cannabis dependence in young adults: an Australian population study. Addiction, 97, 187–194.CrossRefPubMed

Copersino, M. L., Boyd, S. J., Tashkin, D. P., Huestis, M. A., Heishman, S. J., Dermand, J. C., Simmons, M. S., & Gorelick, D. A. (2006). Cannabis withdrawal among non-treatment-seeking adult cannabis users. The American Journal on Addictions, 15, 8–14.CrossRefPubMed

Cornelius, J. R., Chung, T., Martin, C., Wood, D. S., & Clark, D. B. (2008). Cannabis withdrawal is common among treatment-seeking adolescents with cannabis dependence and major depression, and is associated with rapid relapse to dependence. Addictive Behaviors, 33, 1500–1505. doi:10.1016/j.addbeh.2008.02.001.CrossRefPubMedPubMedCentral

Dargan, P. I., Hudson, S., Ramsey, J., & Wood, D. M. (2011). The impact of changes in UK classification of the synthetic cannabinoid receptor agonists in ‘spice’. The International Journal on Drug Policy, 22, 274–277. doi:10.1016/j.drugpo.2011.02.006.CrossRefPubMed

Deluca, P., Schifano, F., Davey, Z., Corazza, O., di Furia, L., Farre, M., Flesland, L., Mannonen, M., Majava, A., Valentina, M., Pagani, S., Peltoniemi, T., Scherbaum, N., Siemann, H., Skutle, A., Torrens, M., Pezzolesi, C., & van der Kreeft, P. (2009). Spice report Psychonaut Web Mapping Research Project. King’s College London: The Psychonaut Web Mapping Research Group.

Dresen, S., Kneisel, S., Weinmann, W., Zimmermann, R., & Auwarter, V. (2011). Development and validation of a liquid chromatography-tandem mass spectrometry method for the quantitation of synthetic cannabinoids of the aminoalkylindole type and methanandamide in serum and its application to forensic samples. Journal of Mass Spectrometry, 46, 163–171. doi:10.1002/jms.1877.CrossRefPubMed

Egan, K. L., Suerken, C. K., Reboussin, B. A., Spangler, J., Wagoner, K. G., Sutfin, E. L., Debinski, B., & Wolfson, M. (2015). K2 and spice use among a cohort of college students in southeast region of the USA. The Am J Drug Alcohol Abuse, 41, 317–322. doi:10.3109/00952990.2015.1043438.CrossRefPubMed

European Monitoring Centre for Drugs and Drug Addiction – EMCDDA (2009) Thematic paper - Understanding the ‘spice’ phenomenon. Office for Official Publications of the European Communities, Luxembourg. Available via DIALOG. http://www.emcdda.europa.eu/publications/thematic-papers/spice. Accessed 28th July 2013.

Ernst, L., Schiebel, H. M., Theuring, C., Lindigkeit, R., & Beuerle, T. (2011). Identification and characterization of JWH-122 used as new ingredient in “spice-like” herbal incenses. Forensic Science International, 208, e31–e35. doi:10.1016/j.forsciint.2011.03.020.CrossRefPubMed

Every-Palmer, S. (2010). Warning: legal synthetic cannabinoid-receptor agonists such as JWH-018 may precipitate psychosis in vulnerable individuals. Addiction, 105, 1859–1860. doi:10.1111/j.1360-0443.2010.03119.x.CrossRefPubMed

Every-Palmer, S. (2011). Synthetic cannabinoid JWH-018 and psychosis: an explorative study. Drug and Alcohol Dependence, 117, 152–157. doi:10.1016/j.drugalcdep.2011.01.012.CrossRefPubMed

Fantegrossi, W. E., Moran, J. H., Radominska-Pandya, A., & Prather, P. L. (2014). Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ9-THC: mechanism underlying greater toxicity? Life Sciences, 97, 45–54. doi:10.1016/j.lfs.2013.09.017.CrossRefPubMed

Fattore, L., & Fratta, W. (2011). Beyond THC: the new generation of cannabinoid designer drugs. Frontiers in Behavioral Neuroscience, 5, 60. doi:10.3389/fnbeh.2011.00060.CrossRefPubMedPubMedCentral

Forrester, M. B., Kleinschmidt, K., Schwarz, E., & Young, A. (2011). Synthetic cannabinoid exposures reported to Texas poison centers. Journal of Addictive Diseases, 30, 351–358. doi:10.1080/10550887.2011.609807.CrossRefPubMed

Gillespie, N. A., Neale, M. C., Prescott, C. A., Aggen, S. H., & Kendler, K. S. (2007). Addiction, 10, 920–930.CrossRef

Gossop, M., Darke, S., Griffiths, P., Hando, J., Powis, B., Hall, W., & Strang, J. (1995). The severity of dependence scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction, 90, 607–614.CrossRefPubMed

Griffiths, P., Sedefov, R., Gallegos, A., & Lopez, D. (2010). How globalization and market innovation challenge how we think about and respond to drug use: ‘spice’ a case study. Addiction, 105, 951–953. doi:10.1111/j.1360-0443.2009.02874.x.CrossRefPubMed

Grigoryev, A., Melnik, A., Savchuk, S., Simonov, A., & Rozhanets, V. (2011a). Gas and liquid chromatography-mass spectrometry studies on the metabolism of the synthetic phenylacetylindole cannabimimetic JWH-250, the psychoactive component of smoking mixtures. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, 879, 2519–2526. doi:10.1016/j.jchromb.2011.07.004.CrossRefPubMed

Grigoryev, A., Savchuk, S., Melnik, A., Moskaleva, N., Dzhurko, J., Ershov, M., Nosyrev, A., Vedenin, A., Izotov, B., Zabirova, I., & Rozhanets, V. (2011b). Chromatography-mass spectrometry studies on the metabolism of synthetic cannabinoids JWH-018 and JWH-073, psychoactive components of smoking mixtures. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, 879, 1126–1136. doi:10.1016/j.jchromb.2011.03.034.CrossRefPubMed

Gunderson, E. W., Haughey, H. M., Ait-Daoud, N., Joshi, A. S., & Hart, C. L. (2012). “spice” and “K2” herbal highs: a case series and systematic review of the clinical effects and biopsychosocial implications of synthetic cannabinoid use in humans. The American Journal on Addictions, 21, 320–326. doi:10.1111/j.1521-0391.2012.00240.x.CrossRefPubMed

Gunderson, E. W., Haughey, H. M., Ait-Daoud, N., Joshi, A. S., & Hart, C. L. (2014). A survey of synthetic cannabinoid consumption by current cannabis users. Substance Abuse, 35, 184–189. doi:10.1080/08897077.2013.846288.CrossRefPubMedPubMedCentral

Helander, A., Beck, O., Hägerkvist, R., & Hulthén, P. (2013). Identification of novel psychoactive drug use in Sweden based on laboratory analysis: initial experiences from the STRIDA project. Scandinavian Journal of Clinical and Laboratory Investigation, 73, 400–406. doi:10.3109/00365513.2013.793817.CrossRefPubMed

Hermanns-Clausen, M., Kneisel, S., Szabo, B., & Auwarter, V. (2013). Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings. Addiction, 108, 534–544. doi:10.1111/j.1360-0443.2012.04078.x.CrossRefPubMed

Hillebrand, J., Olszewski, D., & Sedefov, R. (2010). Legal highs on the internet. Substance Use & Misuse, 45, 330–340. doi:10.3109/10826080903443628.CrossRef

Hudson, S., Ramsey, J., King, L., Timbers, S., Maynard, S., Dargan, P. I., & Wood, D. M. (2010). Use of high-resolution accurate mass spectrometry to detect reported and previously unreported cannabinomimetics in “herbal high” products. Journal of Analytical Toxicology, 34, 252–260.CrossRefPubMed

Hurst, D., Loeffler, G., & McLay, R. (2011). Psychosis associated with synthetic cannabinoid agonists: a case series. The American Journal of Psychiatry, 168, 1119. doi:10.1176/appi.ajp.2011.11010176.CrossRefPubMed

Husserl, E. (1970). Logical investigation. New York: Humanities Press.

Johnston, L. D., O’Malley, P. M., Miech, R. A., Bachman, J. G., & JE, S. (2015). Monitoring the Future national survey results on drug use: 1975-2014: Overview, key findings on adolescent drug use. Institute For Social Research. Ann Arbor, MI: The University of Michigan.

Karlsson, G. (1995). Psychological qualitative research from a phenomenological perspective. Stockholm, Sweden: Almqvist & Wiksell International.

Kavanagh P, Spiers P, O’Brien J, McNamara S, Angelov D, Mullan D, Talbot B, Ryder S (2010) Head shop ‘legal highs’ active constituents identification chart (July/August 2010, ‘714’ – ‘823’). Department of Pharmacology and Therapeutics, TCD, Dublin. Available via http://www.drugs.ie/pdfs/2010/head_shop_ID_poster_may_post_ban.pdf. Accessed 20th July 2015.

Kikura-Hanajiri, R., Uchiyama, N., & Goda, Y. (2011). Survey of current trends in the abuse of psychotropic substances and plants in Japan. Leg Med (Tokyo), 13, 109–115. doi:10.1016/j.legalmed.2011.02.003.CrossRef

Kjellgren, A., & Jonsson, K. (2013). Methoxetamine (MXE)–a phenomenological study of experiences induced by a “legal high” from the internet. Journal of Psychoactive Drugs, 45, 276–286.CrossRefPubMedPubMedCentral

Levasseur, J. J. (2003). The problem of bracketing in phenomenology. Qualitative Health Research, 13, 408–420. doi:10.1177/1049732302250337.CrossRefPubMed

Lincoln, Y. S., & Guba, E. G. (1985). Naturalistic inquiry. Beverly Hills, CA: Sage.

Lindigkeit, R., Boehme, A., Eiserloh, I., Luebbecke, M., Wiggermann, M., Ernst, L., & Beuerle, T. (2009). Spice: A never ending story? Forensic Science International, 191, 58–63. doi:10.1016/j.forsciint.2009.06.008.CrossRefPubMed

McElrath, K., & Van Hout, M. C. (2011). A preference for mephedrone: Drug Markets, drugs of choice and the emerging ‘legal high’ scene. Journal of Drug Issues, 41, 487–507.CrossRef

Meshack A, Peters RJ.Jr, Mi-Ting L, Hill M, Abughosh S, Essien EJ, Savage C (2013) The beliefs of teenage male cannabinoid users: a qualitative study. American Journal of Health Studies 28:109–113.

Müller, H., Huttner, H. B., Kohrmann, M., Wielopolski, J. E., Kornhuber, J., & Sperling, W. (2010a). Panic attack after spice abuse in a patient with ADHD. Pharmacopsychiatry, 43, 152–153. doi:10.1055/s-0029-1243252.CrossRefPubMed

Müller, H., Sperling, W., Kohrmann, M., Huttner, H. B., Kornhuber, J., & Maler, J. M. (2010b). The synthetic cannabinoid spice as a trigger for an acute exacerbation of cannabis induced recurrent psychotic episodes. Schizophrenia Research, 118, 309–310. doi:10.1016/j.schres.2009.12.001.CrossRefPubMed

Pierre, J. M. (2011). Cannabis, synthetic cannabinoids, and psychosis risk: what the evidence says: research suggests marijuana may be a ‘component cause’ of psychosis. Current Psychology, 10, 9.

Rominger, A., Cumming, P., Xiong, G., Koller, G., Forster, S., Zwergal, A., Karamatskos, E., Bartenstein, P., La Fougere, C., & Pogarell, O. (2013). Effects of acute detoxification of the herbal blend ‘spice gold’ on dopamine D2/3 receptor availability: a [18F]fallypride PET study. European Neuropsychopharmacology, 23, 1606–1610. doi:10.1016/j.euroneuro.2013.01.009.CrossRefPubMed

Roussel, O., Carlin, M. G., Bouvot, X., & Tensorer, L. (2015). The emergence of synthetic cannabinoids in Mayotte. Toxicologie Analytique et Clinique, 27, 18–22. doi:10.1016/j.toxac.2014.12.002.CrossRef

Schifano, F., Deluca, P., Baldacchino, A., Peltoniemi, T., Scherbaum, N., Torrens, M., Farre, M., Flores, I., Rossi, M., Eastwood, D., Guionnet, C., Rawaf, S., Agosti, L., Di Furia, L., Brigada, R., Majava, A., Siemann, H., Leoni, M., Tomasin, A., Rovetto, F., & Ghodse, A. H. (2006). Drugs on the web; the Psychonaut 2002 EU project. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 30, 640–646.CrossRef

Schifano, F., Corazza, O., Deluca, P., Davey, Z., Lucia, D. F., Farre, M., Flesland, L., Mannonen, M., Pagani, S., Peltoniemi, T., Pezzolesi, C., Scherbaum, N., Siemann, H., Skutle, A., Torrens, M., & Van Der Kreeft, P. (2009). Psychoactive drug mystical incense? overview of the online available information on spice products. Int J Cult Ment Health, 2, 137–144. doi:10.1080/17542860903350888.CrossRef

Schifano, F., Ricciardi, A., Corazza, O., Deluca, P., Davey, Z., & Rafanelli, C. (2010). New drugs of abuse on the Web: the role of the Psychonaut Web Mapping Project. Rivista di Psichiatria, 45, 88–93.PubMed

Schneir, A. B., Cullen, J., & Ly, B. T. (2011). “spice” girls: synthetic cannabinoid intoxication. The Journal of Emergency Medicine, 40, 296–269. doi:10.1016/j.jemermed.2010.10.014.CrossRefPubMed

Seely, K. A., Prather, P. L., James, L. P., & Moran, J. H. (2011). Marijuana-based drugs: innovative therapeutics or designer drugs of abuse? Molecular Interventions, 11, 36–51. doi:10.1124/mi.11.1.6.CrossRefPubMedPubMedCentral

Seely, K. A., Lapoint, J., Moran, J. H., & Frattore, L. (2012). Spice drugs are more than harmless herbal blends: A review of the pharmacology and toxicology of synthetic cannabinoids. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 39, 234–243. doi:10.1016/j.pnpbp.2012.04.017.CrossRef

Simmons, J. R., Skinner, C. G., Williams, J., Kang, C. S., Schwartz, M. D., & Wills, B. K. (2011a). Intoxication from smoking “spice”. Annals of Emergency Medicine, 57, 187–188. doi:10.1016/j.annemergmed.2010.08.039.CrossRefPubMed

Simmons, J., Cookman, L., Kang, C., & Skinner, C. (2011b). Three cases of “spice” exposure. Clinical Toxicology (Philadelphia, Pa.), 49, 431–433. doi:10.3109/15563650.2011.584316.CrossRef

Sobolevsky, T., Prasolov, I., & Rodchenkov, G. (2010). Detection of JWH-018 metabolites in smoking mixture post-administration urine. Forensic Science International, 200, 141–147. doi:10.1016/j.forsciint.2010.04.003.CrossRefPubMed

Soussan, C., & Kjellgren, A. (2014). The flip side of “spice”: the adverse effects of synthetic cannabinoids as discussed on a Swedish internet forum. Nordic Studies on Alcohol and Drugs, 31, 207–220.CrossRef

Spaderna, M., Addy, P. H., & D’Souza, D. C. (2013). Spicing things up: synthetic cannabinoids. Psychopharmacology, 228, 525–540. doi:10.1007/s00213-013-3188-4.CrossRefPubMedPubMedCentral

Tung, C. K., Chiang, T. P., & Lam, M. (2012). Acute mental disturbance caused by synthetic cannabinoid: a potential emerging substance of abuse in Hong Kong. East Asian Arch Psychiatry, 22, 31–33.PubMed

Tuv, S. S., Strand, M. C., Karinen, R., Øiestad, E. L., Christophersen, A. S., & Vindenes, V. (2012). Effect and occurrence of synthetic cannabinoids. Tidsskrift for den Norske Lægeforening, 132, 2285–2288. doi:10.4045/tidsskr.12.0471.CrossRefPubMed

Uchiyama, N., Kikura-Hanajiri, R., Ogata, J., & Goda, Y. (2010). Chemical analysis of synthetic cannabinoids as designer drugs in herbal products. Forensic Science International, 198, 31–38. doi:10.1016/j.forsciint.2010.01.004.CrossRefPubMed

Van der Veer, N., & Fiday, J. (2011). Persistent psychosis following the use of spice. Schizophrenia Research, 130, 285–286. doi:10.1016/j.schres.2011.04.022.CrossRefPubMed

Van Hout, M. C., & Bingham, T. (2012). A costly turn On: patterns of use and perceived consequences of mephedrone based head shop products amongst Irish injectors. The International Journal on Drug Policy, 23, 188–197. doi:10.1016/j.drugpo.2012.01.008.CrossRefPubMed

Van Hout, M. C., & Brennan, R. (2011a). Plantfood for thought: A qualitative study of mephedrone use in Ireland. Drugs: Educ Prev Polic, 18, 371–381. doi:10.3109/09687637.2010.537713.

Van Hout, M. C., & Brennan, R. (2011b). Bump and grind: An exploratory study of mephedrone users’ perceptions of sexuality and sexual risk. Drug Alcohol Today, 11, 93–104.CrossRef

Van Hout, M. C., & Brennan, R. (2011c). Heads held high: An exploratory study of legal highs in pre legislation Ireland. Journal of Ethnicity in Substance Abuse, 10, 256–272. doi:10.1080/15332640.2011.600210.CrossRefPubMed

Van Hout, M. C., & Brennan, R. (2012). Curiosity killed M-cat: A post legislative study on mephedrone use in Ireland. Drugs: Educ Prev Polic, 19, 156–162.

Vandrey, R., Dunn, K. E., Fry, J. A., & Girling, E. R. (2012). A survey study to characterize use of spice products (synthetic cannabinoids). Drug and Alcohol Dependence, 120, 238–241. doi:10.1016/j.drugalcdep.2011.07.011.CrossRefPubMed

Vardakou, I., Pistos, C., & Spiliopoulou, C. H. (2010). Spice drugs as a new trend: mode of action, identification and legislation. Toxicology Letters, 197, 157–162. doi:10.1016/j.toxlet.2010.06.002.CrossRefPubMed

Vearrier, D., & Osterhoudt, K. C. (2010). A teenager with agitation: higher than she should have climbed. Pediatric Emergency Care, 26, 462–465. doi:10.1097/PEC.0b013e3181e4f416.CrossRefPubMed

Wallendorf, M., & Belk, R. W. (1989). Assessing trustworthiness in naturalistic consumer research. In E. C. Hirschman (Ed.), Interpretive consumer research (pp. 69–84). Provo, UT: Association for Consumer Research.

Westphal, F., Junge, T., Sonnichsen, F., Rosner, P., & Schaper, J. (2010). Ein neuer wirkstoff in SPICE-artigen Kräutermischungen: charakterisierung von JWH-250, seinen methyl-und trimethylsilylderivaten [A new compound in herbal mixtures: characterisation of JWH-250, its methyl- and trimethylsilyl-derivatives]. Toxichem Krimtech, 77, 46–58.

Winstock, A. R., & Barratt, M. J. (2013). Synthetic cannabis: A comparison of patterns of use and effect profile with natural cannabis in a large global sample. Drug and Alcohol Dependence, 131, 106–111. doi:10.1016/j.drugalcdep.2012.12.011.CrossRefPubMed

Zimmermann, U. S., Winkelmann, P. R., Pilhatsch, M., Nees, J. A., Spanagel, R., & Schulz, K. (2009). Withdrawal phenomena and dependence syndrome after the consumption of “spice gold”. Deutsches Ärzteblatt International, 106, 464–467. doi:10.3238/arztebl.2009.0464.PubMedPubMedCentral

Zuba, D., Byrska, B., & Maciow, M. (2011). Comparison of “herbal highs” composition. Analytical and Bioanalytical Chemistry, 400, 119–126. doi:10.1007/s00216-011-4743-7.CrossRefPubMed

Title: User Experiences of Development of Dependence on the Synthetic Cannabinoids, 5f-AKB48 and 5F-PB-22, and Subsequent Withdrawal Syndromes
Authors: Marie Claire Van Hout
Evelyn Hearne
Publication date: 01-06-2017
Publisher: Springer US
Published in: International Journal of Mental Health and Addiction / Issue 3/2017
Print ISSN: 1557-1874
Electronic ISSN: 1557-1882
DOI: https://doi.org/10.1007/s11469-016-9650-x

Keynote webinar | Spotlight on medication adherence

Springer Medicine

User Experiences of Development of Dependence on the Synthetic Cannabinoids, 5f-AKB48 and 5F-PB-22, and Subsequent Withdrawal Syndromes

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2017

Physical Activity and Fitness Outcomes of a Lifestyle Intervention for Primary Care Patients with Depression and Anxiety: a Randomised Controlled Trial

Student’s Academic Engagement: the Relation between Teacher’s Academic Optimism and Female Student’s Perception of School Climate

Mindfulness Training as a Clinical Intervention with Homeless Adults: a Pilot Study

Irish General Practitioner (GP) Perspectives Toward Decriminalisation, Legalisation and Cannabis for Therapeutic Purposes (CTP)

Development and Psychometric Evaluation of the College Eating and Drinking Behaviors Scale in US College Students

Cognitive Reactivity: Cultural Adaptation and Psychometric Testing of the Persian Version of the Leiden Index of Depression Sensitivity Revised (LEIDS-R) in an Iranian Sample